Predicting early mortality after implantable defibrillator implantation: A clinical risk score for optimal patient selection

American Heart Journal

Volumn 151, Issue 2, 2006, Pages 397-403

  Parkash, Ratika ^a   Stevenson, William G ^b   Epstein, Laurence M ^b   Maisel, William H ^b  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT SELECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; SCORING SYSTEM;

AGED; ATRIAL FIBRILLATION; COMORBIDITY; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EPIDEMIOLOGIC METHODS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; PATIENT SELECTION; RENAL INSUFFICIENCY; RISK; STROKE VOLUME;

EID: 31344433759     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.04.009     Document Type: Article

References (34)

1. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) investigators N Engl J Med 337 1997 1576 1583
2. S.J. Connolly, M. Gent, and R.S. Roberts Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone Circulation 101 2000 1297 1302
3. K.H. Kuck, R. Cappato, and J. Siebels Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH) Circulation 102 2000 748 754
4. A.J. Moss, W. Zareba, and W.J. Hall Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
5. G.H. Bardy, K.L. Lee, and D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
6. A.J. Moss, A. Vyas, and H. Greenberg Temporal aspects of improved survival with the implanted defibrillator (MADIT-II) Am J Cardiol 94 2004 312 315
7. H. Greenberg, R.B. Case, and A.J. Moss Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II) J Am Coll Cardiol 43 2004 1459 1465
8. S.H. Hohnloser, K.H. Kuck, and P. Dorian Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction N Engl J Med 351 2004 2481 2488
9. R. Sheldon, S. Connolly, and A. Krahn Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: the Canadian Implantable Defibrillator Study Circulation 101 2000 1660 1664
10. D. Bocker, D. Bansch, and A. Heinecke Potential benefit from implantable cardioverter-defibrillator therapy in patients with and without heart failure Circulation 98 1998 1636 1643
11. F.A. McAlister, J. Ezekowitz, and M. Tonelli Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study Circulation 109 2004 1004 1009
12. S.N. Singh, S.G. Fisher, and P.E. Carson Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. Department of Veterans Affairs CHF STAT Investigators J Am Coll Cardiol 32 1998 942 947
13. D.L. Dries, D.V. Exner, and B.J. Gersh Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction J Am Coll Cardiol 32 1998 695 703
14. D.L. Dries, D.V. Exner, and M.J. Domanski The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction J Am Coll Cardiol 35 2000 681 689
15. T.D. Smilde, H.L. Hillege, and A.A. Voors Prognostic importance of renal function in patients with early heart failure and mild left ventricular dysfunction Am J Cardiol 94 2004 240 243
16. D.L. Dries, D.V. Exner, and B.J. Gersh Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction J Am Coll Cardiol 32 1998 695 703
17. T. Deneke, T. Lawo, and B. Gerritse Mortality of patients with implanted cardioverter/defibrillators in relation to episodes of atrial fibrillation Europace 6 2004 151 158
18. L.F. Fried, M.G. Shlipak, and C. Crump Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals J Am Coll Cardiol 41 2003 1364 1372
19. J.F. Mann, H.C. Gerstein, and J. Pogue Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial Ann Intern Med 134 2001 629 636
20. A.D. Krahn, S.J. Connolly, and R.S. Roberts Diminishing proportional risk of sudden death with advancing age: implications for prevention of sudden death Am Heart J 147 2004 837 840
21. M.O. Sweeney, J.N. Ruskin, and H. Garan Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation Circulation 92 1995 3273 3281
22. G. Pulignano, D. Del Sindaco, and L. Tavazzi Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry) Am Heart J 143 2002 45 55
23. P. Dorian, S. Connolly, and S. Yusuf The impact of left ventricular dysfunction on outcomes with the implantable defibrillator Am Heart J 127 4 Pt 2 1994 1159 1163
24. A.E. Buxton, K.L. Lee, and J.D. Fisher A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators N Engl J Med 341 1999 1882 1890
25. B.L. Wilkoff The Dual Chamber and VVI Implantable Defibrillator (DAVID) trial: rationale, design, results, clinical implications and lessons for future trials Card Electrophysiol Rev 7 2003 468 472
26. M.O. Sweeney, A.S. Hellkamp, and K.A. Ellenbogen Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction Circulation 107 2003 2932 2937
27. M.R. Bristow, L.A. Saxon, and J. Boehmer Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
28. S. Ziesche, T.S. Rector, and J.N. Cohn Interobserver discordance in the classification of mechanisms of death in studies of heart failure J Card Fail 1 1995 127 132
29. J.G. Cleland, L. Erhardt, and A.S. Hall Validation of primary and secondary outcomes and classification of mode of death among patients with clinical evidence of heart failure after a myocardial infarction: a report from the Acute Infarction Ramipril Efficacy (AIRE) study investigators J Cardiovasc Pharmacol 22 Suppl 9 1993 S22 S27
30. R. Narang, J.G. Cleland, and L. Erhardt Mode of death in chronic heart failure. A request and proposition for more accurate classification Eur Heart J 17 1996 1390 1403
31. H.L. Greene, D.W. Richardson, and A.H. Barker Classification of deaths after myocardial infarction as arrhythmic or nonarrythmic (the Cardiac Arrhythmia Pilot Study) Am J Cardiol 63 1989 1 6
32. H.L. Greene Sudden arrhythmic cardiac death-mechanisms, resuscitation and classification: the Seattle perspective Am J Cardiol 65 1990 4B 12B
33. L.E. Hinkle, and H.T. Thaler Clinical classification of cardiac deaths Circulation 65 1982 457 464
34. D.K. Owens, G.D. Sanders, and P.A. Heidenreich Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator Am Heart J 144 2002 440 448